Login

FIRST Shares Norway, positions | Erik Haugland, CEO, First Fondene ASAS OF 30 JUN 2023 00:10:00

Share On Facebook Share On Twitter

Erik Haugland is the CEO of First Fondene AS

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Top Absolute Return Performers: Fatima Khizou’s Picks for Consistent Gains Across Market Cycles | Fatima Khizou - Fund Analyst, Morningstar
00:10:00
Supporting Our Customers Through the COVID-19 Crisis | Calin Rovinescu, CEO, Air Canada.
00:10:00
The Future of Global Trade in a Changing World
00:10:00
Unlocking Value: Analyzing the Schroder Global Recovery Fund’s Investment Strategy | Peter Brunt, Associate Director, Morningstar
00:10:00
VC fund firm focused exclusively on funding entrepreneurs|Greg Mauro,Founder and Managing Partner,Learn Capital
00:10:00
Unveiling Africa's Economic Potential: A Conversation with Tony Elumelu | Tony Elumelu, Founder, Heirs Holdings.
00:10:00
Navigating Investor Confidence and Tech Giants: Insights from Rathbones' Experts | Edward Smith & Sanjiv Tumkur
00:10:00
Chatham Rock Phosphate is the custodian of New Zealand's only material resource of ultra-low cadmium, environmentally friendly pastoral phosphate fertiliser|Chris Castle, President and CEO of Chatham Rock Phosphate Limited
00:10:00
Invests in companies that transforms the quality of living for aging consumers|Alan Patricof,Chairperson,Primetime Partners
00:10:00
Enhancing Employee Retention with Customized Retirement Plans
00:10:00
GTK Director Discusses Sustainable Resource Use and Circular Economy Solutions
00:10:00
Standard Chartered's Perspective on the Future of Digital Assets | Bill Winters, CEO, Standard Chartered.

© 2017 - Neuhu+